SRPT
Sarepta Therapeutics, Inc.Healthcare$23.23
▼ Bearish
Mkt Cap: $2.44B|Float: 91.8M|SI: 24.9%|DTC: 10.4
Data as of market close Apr 2, 2026
IV Rank
6
IV Pctl
22%
HV 20d
125.6%
52W Range
$10-$65
ATR(14)
$1.52
Exp. Move
±6.7%
P/C Ratio
0.86
Earnings
May 6
GEX Positive
DEX Long
Net Put Premium
IV Low
Max Pain Below
Exp. Move Wide
SRPT Key Options Data
- IV Rank
- 6.3%
- Total GEX
- $0.00B
- Total DEX
- $3.1M
- Max Pain
- $17.50
- Expected Move
- ±6.7%
- Put/Call OI
- 0.86
- Net Premium
- $-0.1M
- Spot Price
- $23.23
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$1.55 | ±6.7% | $21.68 | $24.78 |
| 2026-04-17 | 15 | ±$1.95 | ±8.4% | $21.28 | $25.18 |
| 2026-04-24 | 22 | ±$3.60 | ±15.5% | $19.63 | $26.83 |
| 2026-05-01 | 29 | ±$1.83 | ±7.9% | $21.40 | $25.05 |
| 2026-05-15 | 43 | ±$4.85 | ±20.9% | $18.38 | $28.08 |
| 2026-06-18 | 77 | ±$6.35 | ±27.3% | $16.88 | $29.58 |
Explore SRPT options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.